Benzinga | Nov 3, 2021 05:32PM EDT

Evolent Health Q3 EPS $(0.03), Inline, Sales $222.47M Miss $225.62M Estimate

Evolent Health (NYSE:EVH) reported quarterly losses of $(0.03) per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $222.47 million which missed the analyst consensus estimate of $225.62 million by 1.40 percent. This is a 15.92 percent decrease over sales of $264.59 million the same period last year.